$CYTK
Cytokinetics (CYTK) Insider Trading
Cytokinetics, IncorporatedMid Cap$8.8B
Cytokinetics insiders sold $52.1M in the last 12 months, led by Robert Blum, with no insider purchases.
View trades →
Insiders (12-Month)
10 Insiders
View trades →
Insider Buys (12-Month)
No insider buys
Latest Buy
No open-market buys on record
View trades →
Politicians (12-Month)
2 buys · 0 sells
Latest: Rep. Cisneros (D-CA)bought $1K–15K
Sep 29, '26
Recent Insider Trades in CYTK
| Type | Insider | Role | Price | Shares | ΔOwn | Value | Filed |
|---|---|---|---|---|---|---|---|
SELLOE+Sale10b5-1 | Malik Fady Ibraham | EVP Research & Development | $62.93 | 3,500 | −2.2% | -$220,255 | 1d ago |
SELLOE+Sale10b5-1 | Blum Robert I | President & CEO | $62.81 | 7,500 | −2.6% | -$471,075 | 2d ago |
SELLOE+Sale10b5-1 | Malik Fady Ibraham | EVP Research & Development | $64.01 | 3,500 | −2.2% | -$224,035 | Oct 20, '26 |
SELLOE+Sale10b5-1 | Blum Robert I | President & CEO | $62.88 | 7,500 | −2.6% | -$471,600 | Oct 13, '26 |
SELLOE+Sale10b5-1 | Malik Fady Ibraham | EVP Research & Development | $61.38 | 3,500 | −2.2% | -$214,830 | Oct 6, '26 |
SELLOE+Sale10b5-1 | Blum Robert I | President & CEO | $65.46 | 7,500 | −2.6% | -$490,950 | Sep 28, '26 |
SELLOE+Sale10b5-1 | Malik Fady Ibraham | EVP Research & Development | $68.29 | 3,500 | −2.2% | -$239,015 | Sep 22, '26 |
SELL10b5-1 | Landry Robert E | Director | $72.13 | 1,000 | −10.9% | -$72,130 | Sep 15, '26 |
SELLOE+Sale10b5-1 | Blum Robert I | President & CEO | $69.62 | 105,426 | −27.2% | -$7,340,010 | Sep 15, '26 |
SELL10b5-1 | Landry Robert E | Director | $74.66 | 1,000 | −9.8% | -$74,660 | Sep 11, '26 |
SELLOE+Sale10b5-1 | Malik Fady Ibraham | EVP Research & Development | $75.46 | 3,500 | −2.2% | -$264,110 | Sep 8, '26 |
SELL10b5-1 | Parshall B Lynne | Director | $71.48 | 5,000 | −31.7% | -$357,400 | Sep 1, '26 |
SELLOE+Sale10b5-1 | Callos Andrew | EVP, CCO | $70.24 | 10,000 | −14.6% | -$702,400 | Aug 31, '26 |
SELLOE+Sale10b5-1 | Blum Robert I | President & CEO | $70.24 | 7,500 | −1.9% | -$526,800 | Aug 31, '26 |
SELLOE+Sale10b5-1 | Malik Fady Ibraham | EVP Research & Development | $75.82 | 3,500 | −2.2% | -$265,370 | Aug 18, '26 |
SELLOE+Sale10b5-1 | Blum Robert I | President & CEO | $76.76 | 7,500 | −1.9% | -$575,700 | Aug 10, '26 |
SELLOE+Sale10b5-1 | Callos Andrew | EVP, CCO | $79.88 | 14,000 | −19.3% | -$1,118,320 | Jul 30, '26 |
SELLOE+Sale10b5-1 | Blum Robert I | President & CEO | $80.87 | 7,500 | −1.9% | -$606,525 | Jul 27, '26 |
SELLOE+Sale10b5-1 | Malik Fady Ibraham | EVP Research & Development | $80.59 | 3,500 | −2.2% | -$282,065 | Jul 23, '26 |
SELLOE+Sale10b5-1 | Blum Robert I | President & CEO | $82.02 | 7,500 | −1.9% | -$615,150 | Jul 14, '26 |
SELLOE+Sale | Malik Fady Ibraham | EVP Research & Development | $86.62 | 3,500 | −2.2% | -$303,170 | Jul 7, '26 |
SELL | Blum Robert I | President & CEO | $84.92 | 7,500 | −1.9% | -$636,900 | Jul 2, '26 |
SELLOE+Sale | Callos Andrew | EVP, CCO | $85.80 | 15,000 | −20.4% | -$1,287,000 | Jul 2, '26 |
SELLOE+Sale | Lee Sung | EVP, CFO | $87.79 | 1,112 | −1.7% | -$97,622 | Jul 2, '26 |
SELLOE+Sale | Lee Sung | EVP, CFO | $82.30 | 38,730 | −38.0% | -$3,187,479 | Jun 29, '26 |
SELLOE+Sale | Lee Sung | EVP, CFO | $85.00 | 3,134 | −4.7% | -$266,390 | Jun 29, '26 |
SELLOE+Sale | Malik Fady Ibraham | EVP Research & Development | $79.51 | 3,500 | −2.2% | -$278,285 | Jun 23, '26 |
SELL | Blum Robert I | President & CEO | $70.46 | 7,500 | −1.9% | -$528,450 | Jun 15, '26 |
SELLOE+Sale | Malik Fady Ibraham | EVP Research & Development | $67.98 | 3,500 | −2.2% | -$237,930 | Jun 9, '26 |
SELL | Kaye Edward M. MD | Director | $76.09 | 2,933 | −22.2% | -$223,172 | Jun 1, '26 |
SELLOE+Sale | Callos Andrew | EVP, CCO | $74.08 | 15,000 | −20.4% | -$1,111,200 | Jun 1, '26 |
SELL | Parshall B Lynne | Director | $74.08 | 5,000 | −24.1% | -$370,400 | Jun 1, '26 |
SELL | Blum Robert I | President & CEO | $77.21 | 7,500 | −1.9% | -$579,075 | May 28, '26 |
SELLOE+Sale10b5-1 | Malik Fady Ibraham | EVP Research & Development | $75.69 | 3,500 | −2.2% | -$264,915 | May 20, '26 |
SELL | Blum Robert I | President & CEO | $77.92 | 7,500 | −1.8% | -$584,400 | May 14, '26 |
SELLOE+Sale | Malik Fady Ibraham | EVP Research & Development | $77.37 | 3,500 | −2.2% | -$270,795 | May 5, '26 |
SELLOE+Sale | Wierenga Wendell | Director | $75.00 | 4,032 | −11.0% | -$302,400 | May 5, '26 |
SELL | Lee Sung | EVP, CFO | $76.87 | 23,906 | −27.4% | -$1,837,654 | May 5, '26 |
SELLOE+Sale | Henderson John T | Director | $75.97 | 20,000 | −21.0% | -$1,519,400 | May 5, '26 |
SELLOE+Sale10b5-1 | Callos Andrew | EVP, CCO | $77.25 | 11,333 | −16.2% | -$875,474 | May 5, '26 |
SELLOE+Sale | Callos Andrew | EVP, CCO | $65.00 | 15,857 | −21.3% | -$1,030,705 | May 4, '26 |
SELLOE+Sale | Callos Andrew | EVP, CCO | $63.26 | 15,000 | −20.4% | -$948,900 | Apr 30, '26 |
SELL | Blum Robert I | President & CEO | $59.62 | 7,500 | −1.8% | -$447,150 | Apr 29, '26 |
SELLOE+Sale | Malik Fady Ibraham | EVP Research & Development | $65.69 | 3,500 | −2.2% | -$229,915 | Apr 21, '26 |
SELL | Callos Andrew | EVP, CCO | $66.02 | 7,449 | −11.3% | -$491,783 | Apr 15, '26 |
SELL | Blum Robert I | President & CEO | $65.38 | 7,500 | −1.8% | -$490,350 | Apr 15, '26 |
SELLOE+Sale | Malik Fady Ibraham | EVP Research & Development | $65.11 | 4,500 | −2.8% | -$292,985 | Apr 8, '26 |
SELL | Blum Robert I | President & CEO | $66.63 | 7,500 | −1.7% | -$499,725 | Apr 1, '26 |
SELL | Callos Andrew | EVP, CCO | $65.00 | 3,639 | −5.2% | -$236,535 | Mar 31, '26 |
SELL | Lee Sung | EVP, CFO | $62.15 | 4,935 | −5.4% | -$306,710 | Mar 18, '26 |
SELL | Callos Andrew | EVP, CCO | $62.15 | 8,542 | −10.7% | -$530,885 | Mar 18, '26 |
SELL | Malik Fady Ibraham | EVP Research & Development | $62.15 | 12,033 | −7.3% | -$747,851 | Mar 18, '26 |
SELL | Blum Robert I | President & CEO | $62.15 | 36,601 | −7.8% | -$2,274,752 | Mar 18, '26 |
SELL | Callos Andrew | EVP, CCO | $62.07 | 1,930 | −2.4% | -$119,795 | Mar 18, '26 |
SELL | Callos Andrew | EVP, CCO | $61.03 | 1,709 | −3.6% | -$104,300 | Mar 16, '26 |
SELL | Callos Andrew | EVP, CCO | $60.72 | 2,582 | −5.1% | -$156,779 | Mar 10, '26 |
SELL | Malik Fady Ibraham | EVP Research & Development | $60.72 | 2,907 | −2.1% | -$176,513 | Mar 10, '26 |
SELL | Blum Robert I | President & CEO | $60.72 | 7,931 | −2.0% | -$481,570 | Mar 10, '26 |
SELLOE+Sale | Callos Andrew | EVP, CCO | $61.87 | 26,000 | −28.4% | -$1,608,730 | Mar 5, '26 |
SELL | Parshall B Lynne | Director | $61.21 | 5,000 | −21.8% | -$306,050 | Mar 2, '26 |
SELLOE+Sale | Callos Andrew | EVP, CCO | $61.62 | 886 | −1.7% | -$54,595 | Mar 2, '26 |
SELLOE+Sale | Callos Andrew | EVP, CCO | $61.93 | 15,000 | −22.9% | -$928,950 | Feb 6, '26 |
SELLOE+Sale | Callos Andrew | EVP, CCO | $62.10 | 886 | −1.7% | -$55,021 | Feb 2, '26 |
SELLOE+Sale | Callos Andrew | EVP, CCO | $60.28 | 15,000 | −22.9% | -$904,200 | Jan 5, '26 |
SELLOE+Sale | Callos Andrew | EVP, CCO | $62.62 | 1,798 | −3.4% | -$112,585 | Jan 2, '26 |
SELL | Callos Andrew | EVP, CCO | $62.44 | 1,809 | −3.4% | -$112,954 | Dec 30, '25 |
SELLOE+Sale | Wierenga Wendell | Director | $66.14 | 20,000 | −38.1% | -$1,322,800 | Dec 23, '25 |
SELLOE+Sale | Malik Fady Ibraham | EVP Research & Development | $61.24 | 2,200 | −1.6% | -$134,728 | Dec 16, '25 |
SELLOE+Sale | Callos Andrew | EVP, CCO | $65.96 | 1,042 | −2.0% | -$68,730 | Dec 8, '25 |
SELLOE+Sale | Callos Andrew | EVP, CCO | $65.95 | 52,486 | −50.9% | -$3,461,452 | Dec 5, '25 |
SELLOE+Sale | Henderson John T | Director | $63.90 | 8,750 | −10.5% | -$559,125 | Dec 2, '25 |
SELLOE+Sale | Malik Fady Ibraham | EVP Research & Development | $63.89 | 2,200 | −1.5% | -$140,558 | Dec 2, '25 |
SELLOE+Sale | Kaye Edward M. MD | Director | $66.72 | 28,064 | −73.8% | -$1,872,430 | Dec 2, '25 |
SELL | Harrington Robert Arthur | Director | $66.80 | 2,150 | −10.4% | -$143,620 | Dec 2, '25 |
SELL | Parshall B Lynne | Director | $64.73 | 5,000 | −17.9% | -$323,650 | Nov 19, '25 |
SELLOE+Sale | Malik Fady Ibraham | EVP Research & Development | $66.45 | 2,200 | −1.5% | -$146,190 | Nov 18, '25 |
SELLOE+Sale | Kaye Edward M. MD | Director | $65.08 | 5,175 | −34.2% | -$336,789 | Nov 12, '25 |
Older than 12 months | |||||||
SELLOE+Sale | Malik Fady Ibraham | EVP Research & Development | $59.55 | 2,295 | −1.6% | -$136,667 | Nov 5, '25 |
SELL | Blum Robert I | President & CEO | $62.86 | 5,000 | −1.4% | -$314,300 | Oct 30, '25 |
SELLOE+Sale | Wierenga Wendell | Director | $58.68 | 4,375 | −11.9% | -$256,725 | Oct 27, '25 |
SELLOE+Sale | Malik Fady Ibraham | EVP Research & Development | $58.22 | 2,105 | −1.5% | -$122,553 | Oct 21, '25 |
SELL | Blum Robert I | President & CEO | $60.03 | 5,000 | −1.3% | -$300,150 | Oct 16, '25 |
SELLOE+Sale | Malik Fady Ibraham | EVP Research & Development | $60.56 | 2,000 | −1.4% | -$121,120 | Oct 7, '25 |
SELL | Kaye Edward M. MD | Director | $60.00 | 6,757 | −40.9% | -$405,420 | Oct 6, '25 |
SELL | Blum Robert I | President & CEO | $55.05 | 5,000 | −1.3% | -$275,250 | Oct 1, '25 |
SELL | Kaye Edward M. MD | Director | $55.08 | 6,695 | −28.8% | -$368,761 | Sep 30, '25 |
SELLOE+Sale | Malik Fady Ibraham | EVP Research & Development | $49.28 | 2,000 | −1.4% | -$98,560 | Sep 23, '25 |
SELL | Blum Robert I | President & CEO | $49.77 | 5,000 | −1.3% | -$248,850 | Sep 15, '25 |
SELLOE+Sale | Malik Fady Ibraham | EVP Research & Development | $51.29 | 2,000 | −1.4% | -$102,580 | Sep 10, '25 |
SELL | Kaye Edward M. MD | Director | $50.00 | 6,756 | −22.5% | -$337,800 | Sep 2, '25 |
SELL | Harrington Robert Arthur | Director | $48.67 | 2,150 | −9.5% | -$104,641 | Sep 2, '25 |
SELL | Blum Robert I | President & CEO | $48.76 | 5,000 | −1.3% | -$243,800 | Sep 2, '25 |
SELLOE+Sale | Malik Fady Ibraham | EVP Research & Development | $38.31 | 2,000 | −1.4% | -$76,620 | Aug 19, '25 |
SELL | Blum Robert I | President & CEO | $38.42 | 5,000 | −1.3% | -$192,100 | Aug 15, '25 |